Dr. Mansour is currently a tenured Full Professor and Program Leader of the Drug Discovery and Delivery Program at the Florida International University (FIU) Center for Translational Science in Port Saint Lucie, Florida. Joining in February 2022, Professor Mansour has faculty appointments in the Robert Stempel College of Public Health and Social Work (Dept of Environmental Health Sciences), Herbert Wertheim College of Medicine (Dept of Cellular and Molecular Medicine), and College of Engineering (Dept of Biomedical Engineering) . Previously, she was a tenured Associate Professor, Director of the Pharmaceutics/ Pharmacokinetics Track, and Director of the PharmD/PhD dual-degree program at The University of Arizona in Tucson, AZ for 9 years. In addition to being honored as Fellow of the Royal Society of Chemistry (RSC) awarded in 2024, Dr. Mansour is Fellow of the American Institute of Medical and Biological Engineering (AIMBE) inducted in the 2022 Class of College Fellows for innovations in targeted pulmonary inhalation aerosol medicine. A National Academy member, Prof. Mansour is a Senior Member in the National Academy of Inventors (NAI) elected in the 2023 Class of NAI Senior Members. She is the recipient of the 2024 ATS Presidential Commendation honor.
She was funded on the Wisconsin Academic Excellence Scholarship for 4 years at the University of Wisconsin (UW) -Madison and became a Registered Pharmacist. Her PhD degree is in the Pharmaceutical Sciences (Pharmaceutics/Drug Delivery) from the University of Wisconsin-Madison School of Pharmacy where she was funded on AFPE and PhRMA Foundation Predoctoral Fellowships. Dr. Mansour completed Postdoctoral training at the UW-Madison and the University of North Carolina (UNC) at Chapel Hill School of Pharmacy and School of Medicine funded on the PhRMA Foundation Postdoctoral Fellowship.
Dr. Mansour successfully leads multiple cutting-edge research projects that are funded by the NIH. Her first federal grant as PI was from the FDA followed by continuous funding from the NIH. Her innovative research program has produced faculty members who are employed at major research universities in the United States and in the Republic of S. Korea. In addition, her research program has produced Senior Research Scientists who are employed in major pharmaceutical companies in the United States. As Postdoc Mentor, Dr. Mansour has successfully mentored and trained 14 Postdoctoral Research Scholars in her research program. As Major Professor, Dr. Mansour has successfully trained and graduated 5 doctoral graduate students with PhD degrees, as well as Research Assistant Professors. Dr. Mansour successfully completed her 3-year term as Vice Chair of the American Thoracic Society (ATS) Drug/Device Discovery & Development (DDDD) Committee and Chair (2022-2024) of the American Pharmacist Association (APhA) Academy of Pharmaceutical Research and Science (APRS) Basic Sciences. She serves on the PhRMA Foundation Scientific Advisory Committee (Drug Delivery), International Society of Aerosols (ISAM) Executive Board, and Cystic Fibrosis Foundation Scientific Advisory Board. She serves on the Editorial Advisory Boards of the journals Royal Society of Society (RSC) Molecular Systems Design & Engineering (MSDE), RSC Pharmaceutics, Pharmaceutical Technology North America, Frontiers in Drug Delivery-Respiratory Section, Frontiers in Pharmacology-Respiratory Pharmacology Section, and Current Nanomedicine. Dr. Mansour is a founding Associate Editor of the journal, RSC Pharmaceutics, and a Topics Editor of the journal, Pharmaceutics. She has co-edited 2 leading international books on inhalation aerosol medicine and nanomedicine and has published 16 book chapters and 124 journal publications. Dr. Mansour is inventor on 5 issued awarded patents, 5 filed patent applications, and has exclusive licenses.
research interests
Pharmaceutical sciences and USP/FDA translational requirements Nanotechnology and nanomedicine Advanced drug delivery systems Drug-device combination products Inhaled medical aerosols and inhaler devices Microparticles and nanoparticles Controlled release drug delivery Sustained release drug delivery Topical skin drug delivery Transdermal drug delivery In vitro USP/FDA performance testing In vitro 2-D/3-D human cellular models for cell viability and drug transport mechanisms In vitro multicellular spheroids In vivo animal models for therapeutic efficacy and PK/PD CNS and brain neurotherapeutics Cystic fibrosis Infectious diseases Pulmonary hypertension Lung surfactant and respiratory distress syndrome Asthma Acute lung injury Lung transplantation